Skip to main content

Recombinant Human His6-UBE2Q2 Isoform 1 Protein, CF

R&D Systems, part of Bio-Techne | Catalog # E2-745

R&D Systems, part of Bio-Techne
Discontinued Product
E2-745 has been discontinued. View all UBE2Q2 products.

Key Product Details

Source

E. coli

Accession #

Conjugate

Unconjugated

Applications

Enzyme Activity

Product Specifications

Source

E. coli-derived human UBE2Q2 protein
Contains an N-terminal 6-His tag

Purity

>95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain.

Predicted Molecular Mass

44 kDa

SDS-PAGE

44 kDa

Activity

Recombinant Human His6-UBE2Q2-1 is a member of the Ubiquitin-conjugating (E2) enzyme family that receives Ubiquitin from a Ubiquitin-activating (E1) enzyme and subsequently interacts with a Ubiquitin ligase (E3) to conjugate Ubiquitin to substrate proteins. Reaction conditions will need to be optimized for each specific application. We recommend an initial Recombinant Human His6-UBE2Q2-1 concentration of 0.1-1 μM.

Formulation, Preparation and Storage

E2-745
Formulation X mg/ml (X μM) in 50 mM HEPES, pH 7.5, 200 mM NaCl, 10% Glycerol (v/v), 2 mM DTT
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Background: UBE2Q2

Ubiquitin-conjugating Enzyme E2Q Family Member 2 (UBE2Q2) is a 375 amino acid (aa) member of the Ubiquitin-conjugating (E2) enzyme family with a predicted molecular weight of approximately 43 kDa. Human UBE2Q2 shares 95% aa sequence identity with its mouse ortholog. UBE2Q2 contains an RWD domain, a coiled-coil domain, and an E2 catalytic core domain (1). The E2 cataylic core domain contains an active site cysteine residue that is required for the formation of a thioester bond with Ubiquitin (2,3). UBE2Q2 expression has been observed in both the cytoplasm and the nucleus (1,4). Expression of dominant-negative UBE2Q2 can cause a prolonged prophase arrest and UBE2Q2 overexpression inhibits cell proliferation, suggesting that UBE2Q2 may be involved in normal cell cycle progression (3,4). Elevated expression of UBE2Q2 has been reported in hypopharyngeal cancer, breast cancer, and acute lymphoblastic leukemia, suggesting that this enzyme may function as an oncogene (1,4-6). This protein contains an N-terminal 6-His tag.

References

  1. Seghatoleslam, A. et al. (2006) Biochem. Biophys. Res. Commun. 339:422.
  2. Melner, M.H. et al. (2006) Biol. Reprod. 75:395.
  3. Banerjee, S. et al. (2007) Oncogene 26:6509.
  4. Maeda, H. et al. (2009) Mol. Cancer Res. 7:1553.
  5. Nikseresht, M. et al. (2010) Cancer Genet. Cytogenet. 197:101.
  6. Seghatoleslam, A. et al. (2012) Arch. Iran. Med. 15:352.

Long Name

Ubiquitin-conjugating Enzyme E2Q 2

Alternate Names

DKFZp762C143, EC 6.3.2.19, LOC92912, Ubiquitin carrier protein Q2, ubiquitin-conjugating enzyme E2 Q2, ubiquitin-conjugating enzyme E2Q (putative) 2, ubiquitin-conjugating enzyme E2Q family member 2, Ubiquitin-protein ligase Q2

Entrez Gene IDs

92912 (Human); 109161 (Mouse)

Gene Symbol

UBE2Q2

UniProt

Additional UBE2Q2 Products

Product Documents for Recombinant Human His6-UBE2Q2 Isoform 1 Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human His6-UBE2Q2 Isoform 1 Protein, CF

For research use only

Loading...
Loading...